Bovine somatotropin increases the pregnancy rate in fixed-time artificial insemination in beef cattle.

This study evaluated the effect of bovine somatotropin (bST) on pregnancy rate (PR) and size of the dominant follicle (DF) on the day of intravaginal progesterone (P4) removal in protocols for fixed-time artificial insemination (FTAI). Bos indicus (Nellore) females (n = 392) were distributed into three groups. The control group (CG; n = 92) received an intravaginal P4 device + estradiol benzoate on day (d)0; prostaglandin F2α on d7 (first application); removal of P4 + estradiol cypionate (EC) + PGF2α (second application) + ultrasound (US) of the DF on d9; the FTAI was performed on d11; and pregnancy diagnosis (PD) was performed on d45. The bST group (bSTG; n = 142) underwent the same protocol as the CG, except that the animals received 125 mg of bST on d7. The equine chorionic gonadotropin (eCG) group (eCGG; n = 158) underwent the same protocol as the CG, except that the animals received 300 IU of eCG on d9. The PRs of the bSTG, eCGG, and CG were 48%, 48%, and 35%, respectively (p < .05); the bSTG and eCGG showed greater PRs, with follicles 6-7.9 mm (p < .05) and 8-8.9 mm in diameter, respectively. The bSTG exhibited a greater dimension of the DF on d9 of the protocol (p < .05). The eCGG had higher PRs with a body condition score (BCS) of 2.5, and the bSTG had a BCS of 3.0 (p < .05). It was concluded that bST increased PR, bST showed better performance in smaller DF and larger follicular diameter on d9 of the protocol, eCG acted better on animals with lower BCSs, and bST can be used in FTAI.

Indução de lactação em vacas leiteiras com dose hormonal reduzida - projeto piloto / Lactation induction in dairy cows with reduced hormonal dose - Pilot Project

Elevadas taxas de descarte de vacas leiteiras relacionadas a baixos índices reprodutivos são observadas nos rebanhos comerciais. A utilização terapêutica de hormônios no intuito de induzir a lactação em animais hígidos é uma realidade. As doses hormonais utilizadas são elevadas e há a necessidade de experimentos que comprovem a possibilidade de redução. Nesse contexto, o objetivo desse projeto piloto foi reduzir as doses hormonais em vacas leiteiras submetidas a um protocolo de indução de lactação de 0,71mg/kg de peso vivo (PV) de benzoato de estradiol para 0,005mg/kg PV. Quatro vacas leiteiras receberam tratamento hormonal por 18 dias e iniciaram a lactação induzida após esse período. As vacas apresentaram produção de 32±4,3kg no pico lactacional induzido. A resposta lactacional das vacas foi considerada satisfatória e motivadora para experimentação de maior escala. Entretanto, são necessários estudos futuros que comprovem cientificamente o que foi encontrado nesse projeto piloto.

High culling rates of dairy cows related to low reproductive indices are found in commercial herds. The therapeutic use of hormones to induce lactation in healthy animals is a reality. The hormonal doses used are high and there is a need for experiments to prove the possibility of reduction. In this context, this study aimed to reduce the hormonal doses in dairy cows submitted to a lactation induction protocol from 0.71mg/kg of body weight (BW) of estradiol benzoate to 0.005mg/kg BW. Four dairy cows received hormone treatment for 18 days and started the induced lactation after this period. The cows had a production of 32±4.3kg at the induced lactational peak. The lactational response of the cows was considered satisfactory and motivating for larger scale experimentation. However, further studies are needed to scientifically prove what was observed in this pilot project.

Evaluation of growth hormone co-treatment in in vitro fertilization in patients responding better to the GnRH antagonist short protocol.

OBJECTIVE: The present study aims at evaluating the results obtained after in vitro fertilization in bad responders, using controlled ovarian hyperstimulation together with the use of gonadotrophin releasing hormone (GnRH) antagonist (cetrorelix acetate) in a short protocol. METHODS: This is an analytical, longitudinal, retrospective and controlled study involving patients who underwent in vitro fertilization (IVF) procedures in the assisted reproduction program of the Reproferty clinic, in the municipality of São José dos Campos/SP, from January 2012 to December 2016. We collected the data obtained from the medical records of patients considered to have undergone controlled ovarian hyperstimulation using GnRH antagonist (cetrorelix acetate) and Growth Hormone (GH) in a short cycle protocol. The patients considered controls were those submitted to the same hyperstimulation process, without using GH. RESULTS: There were significant differences in the following analyzed parameters: gonadotrophin regimen dose, stimulation duration, and estradiol levels on the day of HCG administration, number of follicles, number of retrieved oocytes, number of mature oocytes and number of good-quality embryos. On the other hand, the GH administration was not significant in the number of cycles that achieved transfer, the number of embryos transferred and the number of frozen cycles. In the case group, there was no increase in the number of cycles that reached pregnancy rate ßhCG+; however, the clinical pregnancy rates and live birth rates were significant. CONCLUSION: The present investigation demonstrated that GH administration as a supplement in poor responders improves the majority of the parameters to achieve a full term pregnancy in these patients.

Efeito da somatotropina bovina recombinante (rbST) na produção in vivo e na maturação in vitro de oócitos bovinos da raça Sindi / Effect of recombinant bovine somatotropin (rbST) on the in vivo production and in vitro maturation of bovine oocytes of the Sindi breed

A fim de avaliar o efeito de diferentes doses da rbST sobre a dinâmica folicular, a produção e a maturação in vitro de oócitos, 20 vacas Sindi, divididas em três grupos, receberam um dispositivo de progesterona intravaginal, estradiol e PGF2α, além de 2mL de solução salina (grupo controle), 250 (grupo rbST 250) ou 500mg de rbST (grupo rbST 500). Cinco dias depois, realizou-se a ovum pick up, e os complexos cumulus-oócitos (CCOs) recuperados foram selecionados, classificados e maturados in vitro. Os dados de contagem foram comparados pelo procedimento glht (General Linear Hypothesis Test), e os dados em porcentagem foram submetidos ao qui-quadrado, no programa estatístico R, onde as diferenças foram consideradas significativas quando P<0,05. Não houve diferença (P>0,05) entre os grupos quanto à quantidade de folículos e à taxa de maturação. Os grupos rbST 250 e rbST 500 foram significativamente superiores (P<0,05) ao grupo controle em relação ao número de folículos grandes (0,42±0,20 vs. 0). O grupo rbST 500 apresentou maior (P<0,05) porcentagem de oócitos viáveis (91,52%) do que os grupos controle (67,85%) e rbST 250 (53,33%). A rbST aumenta o número de folículos grandes, e 500mg de rbST aumentam a porcentagem de oócitos viáveis em vacas Sindi.(AU)

In order to evaluate the effect of different doses of rbST on the follicular dynamics, production, and in vitro maturation of oocytes, 20 Sindhi cows were divided into three groups, receiving an intravaginal progesterone device, estradiol and PGF2α, and 2mL of solution saline (Control Group), 250 (rbST 250 Group) or 500mg rbST (rbST 500 Group). Five days later, the ovum pick up was performed, and the cumulus-oocyte (CCO) complexes recovered were selected, classified, and matured in vitro. The counting data were compared by the glht (General Linear Hypothesis Test) procedure, and the percentage data were submitted to Qui- square, in the statistical program R, where differences were considered significant when P< 0.05. There was no difference (P> 0.05) between the groups regarding follicle quantity and maturation rate. The rbST 250 and rbST 500 groups were significantly higher (P< 0.05) than the Control group in relation to the number of large follicles (0.42±0.20 versus 0). The rbST 500 group presented higher (P< 0.05) percentage of viable oocytes (91.52%) than the Control (67.85%) and rbST 250 (53.33%) groups. rbST increases the number of large follicles and 500mg rbST increases the percentage of viable oocytes in Sindhi cows.(AU)

Efeito da somatotropina bovina recombinante (rbST) na produção in vivo e na maturação in vitro de oócitos bovinos da raça Sindi / Effect of recombinant bovine somatotropin (rbST) on the in vivo production and in vitro maturation of bovine oocytes of the Sindi breed

A fim de avaliar o efeito de diferentes doses da rbST sobre a dinâmica folicular, a produção e a maturação in vitro de oócitos, 20 vacas Sindi, divididas em três grupos, receberam um dispositivo de progesterona intravaginal, estradiol e PGF2α, além de 2mL de solução salina (grupo controle), 250 (grupo rbST 250) ou 500mg de rbST (grupo rbST 500). Cinco dias depois, realizou-se a ovum pick up, e os complexos cumulus-oócitos (CCOs) recuperados foram selecionados, classificados e maturados in vitro. Os dados de contagem foram comparados pelo procedimento glht (General Linear Hypothesis Test), e os dados em porcentagem foram submetidos ao qui-quadrado, no programa estatístico R, onde as diferenças foram consideradas significativas quando P<0,05. Não houve diferença (P>0,05) entre os grupos quanto à quantidade de folículos e à taxa de maturação. Os grupos rbST 250 e rbST 500 foram significativamente superiores (P<0,05) ao grupo controle em relação ao número de folículos grandes (0,42±0,20 vs. 0). O grupo rbST 500 apresentou maior (P<0,05) porcentagem de oócitos viáveis (91,52%) do que os grupos controle (67,85%) e rbST 250 (53,33%). A rbST aumenta o número de folículos grandes, e 500mg de rbST aumentam a porcentagem de oócitos viáveis em vacas Sindi.(AU)

In order to evaluate the effect of different doses of rbST on the follicular dynamics, production, and in vitro maturation of oocytes, 20 Sindhi cows were divided into three groups, receiving an intravaginal progesterone device, estradiol and PGF2α, and 2mL of solution saline (Control Group), 250 (rbST 250 Group) or 500mg rbST (rbST 500 Group). Five days later, the ovum pick up was performed, and the cumulus-oocyte (CCO) complexes recovered were selected, classified, and matured in vitro. The counting data were compared by the glht (General Linear Hypothesis Test) procedure, and the percentage data were submitted to Qui- square, in the statistical program R, where differences were considered significant when P< 0.05. There was no difference (P> 0.05) between the groups regarding follicle quantity and maturation rate. The rbST 250 and rbST 500 groups were significantly higher (P< 0.05) than the Control group in relation to the number of large follicles (0.42±0.20 versus 0). The rbST 500 group presented higher (P< 0.05) percentage of viable oocytes (91.52%) than the Control (67.85%) and rbST 250 (53.33%) groups. rbST increases the number of large follicles and 500mg rbST increases the percentage of viable oocytes in Sindhi cows.(AU)

Effects of recombinant bovine somatotropin on pregnancy per artificial insemination, corpus luteum cellular composition and endometrial gland morphometry in beef cattle.

The aim of this research was to evaluate the effect of recombinant bovine somatotropin (bST) on pregnancy per artificial insemination (P/AI), cellular composition of the corpus luteum (CL) and endometrial gland morphometry. In Experiment 1, Nelore cows (n = 587) received a fixed-time artificial insemination (FTAI) protocol and, at insemination, received 0, 250 or 500 mg of bST subcutaneously (SC). In Experiment 2, Nelore cows (n = 243) received 0 or 500 mg of bST, SC, on D7 (D0 = day of FTAI). Blood samples were collected on D7 and D16 to measure progesterone (P4) concentrations. In Experiments 1 and 2, pregnancy diagnosis was performed 30 days after FTAI. In Experiment 3, Nelore heifers (n = 20) received a FTAI protocol, but were not inseminated, and on D0 (ovulation day), they received 0 (bST 0; n = 9) or 500 mg of bST (bST 500; n = 11), SC. The heifers were slaughtered on D15 (D0 = ovulation day), at which time the CL was evaluated for diameter, weight, a percentage of large (LLC) and small (SLC) luteal cells, and the concentration of progesterone in plasma measured. The number, perimeter and area of superficial and deep endometrial glands were evaluated. There was no difference in P/AI when bST was applied on D0 and D7. In Experiment 1, P/AI did not differ among treatments, with 59.28% (115/194), 58.38% (115/197) and 65.82% (129/196) for the bST 0, 250 and 500 treatments, respectively. In Experiment 2, P/AI did not differ between treatments, with 57.3% (71/124) and 60.5% (62/119) for the bST 0 and 500 treatments, respectively. Plasma progesterone concentrations on D16 was greater in the bST 500 (11.63 ±â€¯0.84 ng/mL) than bST 0 (9.83 ±â€¯0.88 ng/mL). In Experiment 3, there was no difference in ovarian diameter and weight, CL diameter, percentage of SLC, P4 concentrations and endometrial gland morphology. Heifers in the bST 500 treatment had heavier CL (3.11 ±â€¯0.32 vs. 2.25 ±â€¯0.20 g); however, the bST 0 treatment heifers had a greater percentage of LLC than did the bST 500 treatment (13.72 ±â€¯1.16% vs. 8.60 ±â€¯1.52). It was concluded that the doses of bST used in this study do not increase P/AI; however, they do cause changes in P4 concentration and the cellular composition of the CL.

Effect of growth hormone (GH) and resistance training on the collagen properties of femoral bone tissue / Efecto de la hormona de crecimiento (HC) y el entrenamiento de fuerza en las propiedades colágenas del tejido óseo femoral

The indiscriminate use of anabolic steroids in gyms has been growing in a generalized way, among which, the most common is growth hormone (GH). In the short term GH may potentiate muscle growth, especially when taken in combination with resistance training. However, the effects of this hormone are not yet fully understood in the literature, especially in relation to collagen properties. The objective of this study was to evaluate the effect of the application of growth hormone (GH) and resistance training (RT) on the collagen properties of femoral bone tissue using Raman Spectroscopy. In this study 40 male rats were randomly distributed into four groups (n=10): control (C), control and GH application (GH), resistance training (T), and resistance training and GH application (GHT). The training consisted of four series of 10 water jumps, performed three times a week, with an overload corresponding to 50 % of body weight and duration of four weeks. GH was applied at a dosage of 0.2 IU/Kg (0.067 mg/kg) to each animal, three times a week, every other day. The animals were euthanized and the right femurs were collected for analysis of bone structure. Raman spectroscopy (RS) was used to observe the following compounds from their respective bands: type I collagen (662 cm-1), amide III (1243 cm-1), proteins including type I collagen (1278 cm-1), woven collagen (1322 cm-1), association of collagen, phospholipids, nucleic acid, and phosphate (1330 cm-1), and collagen and protein deformation (1448 cm-1). The results demonstrated an increase in the collagen properties in all analyzed variables, however, the T group presented a statistically significant difference (p<0.05). It is possible to conclude that isolated physical training was shown to be more efficient than when combined with the application of GH to increase the collagen properties of the femoral bone tissue.

El uso indiscriminado de anabolizantes en los gimnasios ha aumentado de forma generalizada, entre éstos la hormona de crecimiento (HC) es una de las más utilizadas, y a corto plazo puede potencializar el crecimiento muscular, principalmente cuando es realizado en combinación con el entrenamiento de fuerza. Sin embargo, los efectos de esta hormona aún no están totalmente esclarecidos en la literatura, especialmente en relación a las propiedades colágenas. El objetivo del estudio fue evaluar el efecto de la aplicación del HC y entrenamiento de fuerza (E) en las propiedades colágenas del tejido óseo femoral a partir de la utilización de la espectroscopía Raman. Se usaron 40 ratas Wistar distribuidos en cuatro grupos (n=10): control (C), control y aplicación del HC (HCC), entrenamiento de fuerza (E) y entrenamiento de fuerza y aplicación del HC (THC). El entrenamiento fue compuesto por cuatro series de 10 saltos acuáticos, realizados tres veces por semana, con sobrecarga correspondiente a 50 % del peso corporal y duración de cuatro semanas. El HC fue aplicado en una dosificación de 0,2 UI/Kg (0,067 mg/kg) en cada animal, tres veces por semana, en días no consecutivos. Los animales fueran eutanasiados y se retiró el fémur derecho para realización del análisis de la estructura ósea. La espectroscopía Raman (ER) fue utilizada para observar los siguientes compuestos a partir de las respectivas bandas: colágeno tipo I (662 cm-1), amida III (1243 cm1), proteínas, incluido colágeno tipo I (1278 cm-1), colágeno retorcido (1322 cm-1), asociación de colágeno, fosfolípidos, ácidos nucleicos y fosfato (1330 cm-1), deformación de colágeno y proteína (1448 cm-1). Hubo aumento en las propiedades colágenas en todas las variables analizadas, sin embargo, solamente el grupo E demostró una diferencia estadísticamente significativa (p<0,05). En conclusión, para el aumento de las propiedades colágenas del tejido óseo femoral, el entrenamiento físico aislado es más eficiente que el entrenamiento combinado con el uso de HC.

Aplicaciones de la hormona de crecimiento humana recombinante en HIV. Efectos sobre el aparato inmune / Aplication of the recombinant human growth hormone in HIV. Effects on the immune system

El presente trabajo realiza una investigación bibliográfica sobre el uso clínico de RhGH en pacientes adultos HIV en su rol inmunomodulador mediante búsqueda booleana en Pubmed de los términos RhGH yHIV en artículos de ensayos clínicos, únicamente en adultos a partir de los 19 o más años de edad hasta enero del 2019

Impact of recombinant bovine somatotropin, progesterone, and estradiol benzoate on ovarian follicular dynamics in Bos taurus taurus cows using a protocol for estrus and ovulation synchronization.

This study aimed to evaluate the effect of recombinant bovine somatotropin (bST) in combination with progesterone (P4) and estradiol benzoate (EB) on ovarian follicular dynamics using a protocol for estrus and ovulation synchronization in crossbred Bos taurus taurus cows. Twenty-four non-lactating multiparous cows were randomly assigned to two groups: the recombinant bovine somatotropin group (GbST; n = 11) received an intravaginal P4 device (1.5 g), estradiol benzoate (EB = 1.0 mg IM), bST (500 mg SC), and an ovarian ultrasonography (US) on day zero (d0 = beginning of the study); d-cloprostenol (150 µg, IM), US, and P4 removal on d8; 1.0 mg of EB (IM) on d9; and US on d10 and d15. On the other hand, to the control group (GC; n = 13), the same protocol as the GbST was applied, except for the non-receipt of bST on d0. The follicles were measured and evaluated on d0, d8, and d10, as were the corpora lutea (CL) on d15 (using ultrasonography). The effect of the two treatments (GbST vs. GC) on the follicle size, CL (F-test), and ovulation rate (logistic regression) were evaluated. The GbST showed a greater follicle diameter on d10 (14.5 mm) than the GC (12.1 mm; P < 0.03), as well as a greater diameter of CL on d15 (19.7 vs. 16.9 mm, P < 0.01). In addition, in the former, the ovulation rate (90.9 vs. 69.2%, P = 0.09) was observed to be greater. It was concluded that the combination of bST, P4, and EB in synchronization for estrus and ovulation protocols significantly increased the diameter of the preovulatory follicle, produced a higher follicular growth rate, and a greater diameter of the corpus luteum. Additionally, there was a higher percentage of cows with ovulation compared to the group that did not receive bST.

Muscle strength training is better than the use of growth hormone (GH) in bone health of Wistar rats / Entrenamiento de la fuerza muscular es mejor que el uso de la hormona del crecimiento (GH) en salud ósea del ratas Wistar

SUMMARY: The objective of this study was to evaluate the effects of growth hormone (GH) and muscle strength training (ST) on the composition of bone tissue of Wistar rats through Raman spectroscopy. In total, 40 male rats were randomly distributed into four groups: (N = 10) control (C), control with the application of GH (GHC), strength training (T), and strength training with the application of GH (GHT). The training consisted of four series of 10 water jumps, performed three times a week, with an overload corresponding to 50 % of body weight and duration of four weeks. GH was applied at a dose of 0.2 IU / kg in each animal three times a week and every other day. After four weeks, the animals were euthanized and the right femurs collected for analysis of the bone structure. Raman spectroscopy (ER) was used to observe the following compounds from their respective bands: Calcium Carbonate-Triglycerides (fatty acids) 1073 cm-1, Collagen type I 509 cm-1, Bone-DNA Phosphate (Protein) 589 cm-1, Phosphate Phospholipids 1078 cm-1. For the statistical analysis, the Shapiro-Wilk and ANOVA One-Way variance analysis normality tests were performed, followed by the Tukey post-test. The results showed an increase in the concentrations of calcium carbonate-triglycerides (fatty acids), type I collagen, bone phosphate-DNA (protein), and phosphate phospholipids in all experimental groups, with or without ST and/or GH , But only the isolated training group differed significantly from the control group (P <0.05). It was concluded that all treatments could promote bone tissue gain, however, only the T group demonstrated a significant difference in the mineral compounds analyzed.

RESUMEN: El objetivo del estudio fue avaluar el efecto de la aplicación de la hormona del crecimiento (GH) y entrenamiento de la fuerza muscular (EF) en la composición del tejido óseo de ratas Wistar a partir de la espectroscopía Raman. Fueron utilizadas 40 ratas machos distribuidas de forma aleatoria en cuatro grupos (n=10): control (C), control y aplicación de GH (GHC), entrenamiento de la fuerza muscular (EF) y entrenamiento de la fuerza muscular y aplicación del GH (GHE). El entrenamiento fue consistió en cuatro series de 10 saltos acuáticos, realizados tres veces en la semana, con sobrecarga correspondiente a 50 % de la masa corporal y durante cuatro semanas. El GH fue aplicado en la dosificación de 0,2 UI/kg en cada animal, tres veces en la semana y en días alternados. Después de cuatro semanas, los animales fueran eutanasiados y retirados los fémures derechos para un análisis de la estructura ósea. La espectroscopía Raman fue utilizada para observar los siguientes compuestos a partir de las respectivas bandas: Carbonato de Calcio-Triglicéridos (ácidos grasos) 1073 cm-1, Colágeno Tipo I 509 cm-1, Fosfato Óseo-DNA (Proteína) 589 cm1, Fosfato Fosfolípidos 1078 cm-1. Para el análisis estadístico, fueron realizadas las pruebas Shapiro-Wilk y el análisis de variancia ANOVA One-Way, seguida de test post hoc de Tukey. Los resultados revelaran aumento de la concentración de Carbonato de Calcio-Triglicéridos (ácidos grasos), Colágeno Tipo I, Fosfato Óseo- DNA (Proteína), Fosfato Fosfolípidos en todos los grupos experimentales, asociados o no a la realización del EF y/o aplicación del GH. Además, solamente el grupo EF mostró diferencia significativa del grupo C (p<0,05). Es posible concluir que todos los tratamientos mostraran aumentos en el tejido óseo, sin embargo, solamente el grupo T demostró una diferencia significativa en los compuestos minerales analizados.

Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation.

BACKGROUND: Somatotropic axis dysfunction associated with non-alcoholic fatty liver disease (NAFLD) has potential multisystemic detrimental effects. Here, we analysed the effects of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) supplementation on liver histology, adipokine profile and muscle function in an NAFLD model. METHODS: C57BL/6 mice were fed with a high fat diet (HFD) for 12 weeks and were separated into three groups treated for 4 weeks with: (1) High fat diet (HFD) (n = 10); (2) HFD + GH 9 μg/g/d (n = 10); (3) HFD + IGF-1 0.02 µg/g/d (n = 9). A control group fed a chow diet was included (n = 6). Liver histology, liver triglycerides content, serum alanine aminotransferase (ALT) activity, adiponectin and leptin serum levels, in vivo muscle strength, tetanic force and muscle fibre cross-sectional area (CSA) were measured. RESULTS: HFD + GH and HFD + IGF-1 groups showed significantly lower ALT activity compared to HFD (p < 0.01). Liver triglyceride content in HFD + GH was decreased compared to HFD (p < 0.01). Histologic steatosis score was increased in HFD and HFD + GH group (p < 0.01), whereas HFD + IGF-1 presented no difference compared to the chow group (p = 0.3). HFD + GH group presented lower serum leptin and adiponectin levels compared to HFD. GH and IGF-1 supplementation therapy reverted HFD-induced reduction in muscle strength and CSA (sarcopenia). CONCLUSIONS: GH and IGF-1 supplementation induced significant improvement in liver steatosis, aminotransferases and sarcopenia in a diet-induced NAFLD model.

Expression profile of glucose transport-related genes under chronic and acute exposure to growth hormone in zebrafish.

The brain is a highly demanding organ in terms of energy requirements, and precise regulatory mechanisms must operate to ensure adequate energy delivery to maintain normal neuronal activity. Of the energy-promoting substrates present in the circulation, glucose is preferred by the brain, and as with all other substrates, its utilization depends on the presence of humoral factors such as hormones including growth hormone (GH). Glucose enters the cells though specific transport proteins. Among all transporter families and subtypes described to date, the most studied ones are the glucose transporters (GLUTs). The aim of this study is to determine a possible relationship between GH and GLUTs. Therefore, we evaluated the effect of GH-transgenesis and recombinant GH injections upon GLUT expression in the brain of male zebrafish. Overall, the results demonstrated that increasing the GH concentrations above the normal level, via transgenesis or injection, in the fish may impair energy uptake by the brain. This appeared to occur through downregulation of most of the analyzed GLUTs.

Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?

This brief review of the neurological effects of growth hormone (GH) and gonadotropin-releasing hormone (GnRH) in the brain, particularly in the cerebral cortex, hypothalamus, hippocampus, cerebellum, spinal cord, neural retina, and brain tumors, summarizes recent information about their therapeutic potential as treatments for different neuropathologies and neurodegenerative processes. The effect of GH and GnRH (by independent administration) has been associated with beneficial impacts in patients with brain trauma and spinal cord injuries. Both GH and GnRH have demonstrated potent neurotrophic, neuroprotective, and neuroregenerative action. Positive behavioral and cognitive effects are also associated with GH and GnRH administration. Increasing evidence suggests the possibility of a multifactorial therapy that includes both GH and GnRH.

Lipidograma, função hepática e produção de leite em vacas suplementadas com somatotropina recombinante bovina / Serum lipid profile, hepatic function and milk production in cows supplemented with bovine recombinant somatotropin / Perfil de lípidos séricos, función hepática y producción de leche en vacas suplementadas con somatotropina bovina recombinante

O uso de bST é uma ferramenta que propicia um aumento considerável na produção diária de leite. Entretanto, esta suplementação pode ter influencia na função hepática e no lipidograma. Sendo assim, o objetivo deste estudo foi avaliar o perfil lipídico e hepático e também a produção láctea de vacas suplementadas com este hormônio. Para isso, foram utilizadas 10 vacas em produção, 90 dias pós-parto, com média de 30 litros/dia. Realizaram-se cinco aplicações com intervalo de 14 dias entre elas. As coletas de sangue para análise de colesterol, triglicerídeos, AST, GGT e albumina foram feitas nos dias zero, 20, 40 e 60 do experimento. Já a produção de leite foi avaliada em três momentos dentro do período de 70 dias. Não houve diferença entre os grupos em nenhum dos parâmetros avaliados tanto para perfil lipídico e função hepática, entretanto, promoveu uma maior produção de leite no período estudado. Sendo assim, conclui-se que a suplementação de bST não exerce influência negativa sobre o lipidograma de vacas leiteiras em produção, bem como não causa dano hepático durante a suplementação deste hormônio por um período de 70 dias e, também possibilita uma maior produção de leite neste período.

Milk production has a considerable increase with the use of bST in dairy cows. However, this supplementation may have influence on liver function and serum lipid profile. Thus, the aim of this study was to evaluate the serum lipid profile and liver profile and milk production in cows supplemented with this hormone. For this, were used ten dairy cows, 90 days postpartum, with an average of 30 liters/day. Was performed five applications with an interval of 14 days between them. Blood samples for analysis of cholesterol, triglycerides, AST, GGT and albumin were made on days zero, 20, 40 and 60 of the experiment. The production of milk was evaluated in three times within 70 days. There was no difference between groups in any of the parameters evaluated for both serum lipid profile and liver function, but milk production was increased in control group. Therefore, it is concluded that supplementation of bST does not result negative influence on the serum lipid profile of dairy cows in production, and does not cause liver damage in supplementation for a period of 70 days, and increases milk production in this period.

El uso de la bST es una herramienta que proporciona un aumento considerable en la producción de leche diaria. Sin embargo, esta suplementación puede tener influencia en la función hepática y perfil lipídico. Por lo tanto, el objetivo de este estudio fue evaluar el perfil lipídico y hepatico y también la producción de leche de vacas alimentadas con esta hormona. Para este fin, se utilizaron 10 vacas en producción, 90 días después del parto, con un promedio de 30 litros/día. Se realizó cinco veces con un intervalo de 14 días entre ellos. Las muestras de sangre para análisis de colesterol, triglicéridos, AST, GGT y la albúmina se hicieron a cero, 20, 40 y 60 días del experimento. La producción de leche se evaluó en tres veces dentro del periodo de 70 días. No hubo diferencias entre los grupos en cualquiera de los parámetros evaluados para el perfil lipídico y la función del hígado, sin embargo, promueve una mayor producción de leche durante el período estudiado mucho. Por lo tanto, se concluye que la suplementación de la bST no ejerce influencia negativa sobre la producción de lípidos en vacas lecheras, y no causa daños en el hígado durante la suplementación de esta hormona durante un período de 70 días y también permite una mayor producción de leche este período.

Lipidograma, função hepática e produção de leite em vacas suplementadas com somatotropina recombinante bovina / Serum lipid profile, hepatic function and milk production in cows supplemented with bovine recombinant somatotropin / Perfil de lípidos séricos, función hepática y producción de leche en vacas suplementadas con somatotropina bovina recombinante

O uso de bST é uma ferramenta que propicia um aumento considerável na produção diária de leite. Entretanto, esta suplementação pode ter influencia na função hepática e no lipidograma. Sendo assim, o objetivo deste estudo foi avaliar o perfil lipídico e hepático e também a produção láctea de vacas suplementadas com este hormônio. Para isso, foram utilizadas 10 vacas em produção, 90 dias pós-parto, com média de 30 litros/dia. Realizaram-se cinco aplicações com intervalo de 14 dias entre elas. As coletas de sangue para análise de colesterol, triglicerídeos, AST, GGT e albumina foram feitas nos dias zero, 20, 40 e 60 do experimento. Já a produção de leite foi avaliada em três momentos dentro do período de 70 dias. Não houve diferença entre os grupos em nenhum dos parâmetros avaliados tanto para perfil lipídico e função hepática, entretanto, promoveu uma maior produção de leite no período estudado. Sendo assim, conclui-se que a suplementação de bST não exerce influência negativa sobre o lipidograma de vacas leiteiras em produção, bem como não causa dano hepático durante a suplementação deste hormônio por um período de 70 dias e, também possibilita uma maior produção de leite neste período.(AU)

Milk production has a considerable increase with the use of bST in dairy cows. However, this supplementation may have influence on liver function and serum lipid profile. Thus, the aim of this study was to evaluate the serum lipid profile and liver profile and milk production in cows supplemented with this hormone. For this, were used ten dairy cows, 90 days postpartum, with an average of 30 liters/day. Was performed five applications with an interval of 14 days between them. Blood samples for analysis of cholesterol, triglycerides, AST, GGT and albumin were made on days zero, 20, 40 and 60 of the experiment. The production of milk was evaluated in three times within 70 days. There was no difference between groups in any of the parameters evaluated for both serum lipid profile and liver function, but milk production was increased in control group. Therefore, it is concluded that supplementation of bST does not result negative influence on the serum lipid profile of dairy cows in production, and does not cause liver damage in supplementation for a period of 70 days, and increases milk production in this period.(AU)

El uso de la bST es una herramienta que proporciona un aumento considerable en la producción de leche diaria. Sin embargo, esta suplementación puede tener influencia en la función hepática y perfil lipídico. Por lo tanto, el objetivo de este estudio fue evaluar el perfil lipídico y hepatico y también la producción de leche de vacas alimentadas con esta hormona. Para este fin, se utilizaron 10 vacas en producción, 90 días después del parto, con un promedio de 30 litros/día. Se realizó cinco veces con un intervalo de 14 días entre ellos. Las muestras de sangre para análisis de colesterol, triglicéridos, AST, GGT y la albúmina se hicieron a cero, 20, 40 y 60 días del experimento. La producción de leche se evaluó en tres veces dentro del periodo de 70 días. No hubo diferencias entre los grupos en cualquiera de los parámetros evaluados para el perfil lipídico y la función del hígado, sin embargo, promueve una mayor producción de leche durante el período estudiado mucho. Por lo tanto, se concluye que la suplementación de la bST no ejerce influencia negativa sobre la producción de lípidos en vacas lecheras, y no causa daños en el hígado durante la suplementación de esta hormona durante un período de 70 días y también permite una mayor producción de leche este período.(AU)

Morphometric study of muscle fibers in rats submitted to strength training and growth hormone / Estudio morfométrico de las fibras musculares de ratas sometidos a entrenamiento de la fuerza muscular y hormona del crecimiento

The aim of the present study was to observe the changes in the muscle tissue of rats after application of growth hormone (GH) and performing a strength training protocol (ST). In total, 40 male Wistar rats, 60 days old, were used, divided into four groups: control (C), control and application of GH (GHC), strength training (T), and strength training with the application of GH (GHT). The physical training protocol (PT) was composed of four series of 10 jumps in water, 3x/week, with an overload of 50 % of body weight for four weeks. GH was administered intraperitoneally at a dose of 0.2 IU/Kg to the GHC and GHT groups and saline (0.9 % sodium chloride) to the C and T groups. After four weeks of PT, the animals were euthanized and samples taken from the Soleus muscle. Histological sections were produced with a thickness of 5 mm and stained with hematoxylin-eosin (HE) and nicotinamide adenine dinucleotide tetrazolium reductase (NADH-TR). The markings for determining the measurement of the smallest diameter of muscle fibers (MF) were carried out using the software (AuxioVisionRel 4.8-Carl Zeiss® and NIS-Elements D3.0-SP7-Nikon®). After obtaining the data, the Shapiro-Wilk test for normality was performed and then the nonparametric Kruskal-Wallis with Dunn post-test were used for analysis of MF and the Student t test for the analysis of intragroup body weights. All procedures adopted a 5 % significance value (p <0.05) and were performed using the software SPSS 22.0 for Windows®. It was observed that both the GH and PT were able to generate increased diameter of MF (C:31.81±6.35; GHC:36.88±6.38; T:38.38± 6.94; GHT:36.89±7.16). Moreover, when analyzing the type, a significant increase was found only in the fast twitch MF (C:33.78±7.78; GHC:37.80±6.03; T:38.53±6.94; GHT:37.98±7.65) when compared to the slow twitch (C:25.93±6.66; GHC:26.95±8.03; T:26.24±6.90; GHT:27.20±5.77).

El objetivo de la investigación fue observar las modificaciones en tejido muscular esquelético de ratas después de la aplicación de la hormona del crecimiento (GH) y posterior entrenamiento de fuerza muscular (EFM). Fueran utilizadas 40 ratas Wistar, con 60 días de edad, distribuidas en: control (C), control y aplicación de la hormona del crecimiento (GHC), entrenamiento de fuerza muscular (T), y entrenamiento de fuerza muscular y hormona del crecimiento (GHT). El protocolo de entrenamiento (PT) fue compuesto por cuatro series de diez saltos acuáticos, 3x/semana, con sobrecarga de 50 % del peso corporal, por cuatro semanas. El GH fue aplicado de forma intraperitoneal con una dosis de 0,2UI/kg en grupos GHC y GHT y solución salina (0,9% clorhidrato de sodio) en grupos C y T. Después de cuatro semanas del PT, los animales fueron sacrificados y retirados los músculos sóleos. Se realizaron cortes de 5 µm los que fueron coloreados con Hematoxilina y Eosina (HE), posteriormente fueron sometidos a reacción con nicotinamida adenina dinucleotide tetrazolium reductasa (NADH-TR). Después de la obtención de los datos, fue utilizado la prueba del Shapiro-Wilk para la verificación de la normalidad de los datos y se usó el ensayo de Kruskal-Wallis con pos verificación del Dunn para análisis de las fibras musculares (FM) y prueba t del Student para la análisis del peso corporal entre los grupos. Todos los procedimientos fueron establecidos con valor de la significancia de 5 % (p<0,05) y realizados con el software SPSS 22.0 for Windows®. Fue verificado que tanto lo GH cuanto lo PT fueran capaces de proporcionar el aumento en el diámetro de las FM (C:31.81±6.35; GHC:36.88±6.38; T:38.38±6.94; GHT:36.89±7.16). En relación al tipo de fibras se observó aumento significativo solamente en las FM de contracción rápida (C:33.78±7.78; GHC:37.80±6.03; T:38.53±6.94; GHT:37.98±7.65) cuando se comparó con las FM de contracción lenta (C:25.93±6.66; GHC:26.95±8.03; T:26.24±6.90; GHT:27.20±5.77).

Distribution of growth hormone-responsive cells in the mouse brain.

Growth hormone (GH) exerts important biological effects primarily related to growth and metabolism. However, the role of GH signaling in the brain is still elusive. To better understand GH functions in the brain, we mapped the distribution of GH-responsive cells and identified the receptors involved in GH central effects. For this purpose, mice received an acute intraperitoneal challenge with specific ligands of the GH receptor (mouse GH), prolactin receptor (prolactin) or both receptors (human GH), and their brains were subsequently processed immunohistochemically to detect the phosphorylated form of STAT5 (pSTAT5). GH induced pSTAT5 immunoreactivity in neurons, but not in astroglial cells of numerous brain regions, including the cerebral cortex, nucleus accumbens, hippocampus, septum and amygdala. The most prominent populations of GH-responsive neurons were located in hypothalamic areas, including several preoptic divisions, and the supraoptic, paraventricular, suprachiasmatic, periventricular, arcuate, ventromedial, dorsomedial, tuberal, posterior and ventral premammillary nuclei. Interestingly, many brainstem structures also exhibited GH-responsive cells. Experiments combining immunohistochemistry for pSTAT5 and in situ hybridization for GH and prolactin receptors revealed that human GH induced pSTAT5 in most, but not all, brain regions through both prolactin and GH receptors. Additionally, males and females exhibited a similar number of GH-responsive cells in forebrain structures known to be sexually dimorphic. In summary, we found GH-responsive cells primarily distributed in brain regions implicated in neurovegetative, emotional/motivational and cognitive functions. Our findings deepen the understanding of GH signaling in the brain and suggest that central GH signaling is likely more ample and complex than formerly recognized.

Relación entre tratamiento con hormona de crecimiento y perfiles de personalidad en mujeres con diagnóstico de Síndrome de Turner / Relationship between growth hormone treatment and personality profiles in women diagnosed with Turner Syndrome

El objetivo del presente trabajo fue identificar la existencia de perfiles distintivos en las escalas de personalidad en relación con la aplicación o no de hormona de crecimiento en 73 mujeres adultas con diagnóstico de Síndrome de Turner de Latinoamérica. Para ello se administró, en formato online, el Inventario Clínico Multiaxial de Millon II y un cuestionario clínico para recabar datos sobre la realización o no de tratamiento con hormona de crecimiento durante el desarrollo con el fin de omparar ambos grupos. Los resultados encontrados muestran que el grupo que no realizó tratamiento con hormona de crecimiento obtiene medias más altas en casi la totalidad de las escalas de personalidad básicas y patológicas en comparación con el grupo que sírealizó tratamiento, siendo dicha diferencia significativa en la escala esquizotípica. Esta escala se asocia con necesidades afectivas mínimas, aislamiento social y apego empobrecido. Estos resultados podrían dar cuenta que el tratamiento con hormona de crecimiento sería un factor positivo para esta población, favoreciendo el desarrollo de características de personalidad más adaptativas en relación a lo social.

The aim of this study was to identify the existence of distinctive profiles on the personality scales in relation to the application or not of the growth hormone in 73 adult women diagnosed with Turner Syndrome in Latin America. For it was administered, in online form, the Millon Clinical Multiaxial Inventory II and a clinical questionnaire to collect data on the realization or non-treatment with growth hormone during development in order to compare both groups. The results show that the group did not make growth hormone treatment gets highest averages in nearly all of the basic and pathological personality scales compared to the group that if he completed treatment, being such significant difference in schizotypal scale. This scale is associatedwith minimal emotional needs, social isolation and impoverished attachment. These results might note that treatment with growth hormone could be a positive factorfor this population, favoring the development of more adaptive personality characteristics in relation to the social aspects.

Effects of Growth Hormone on In Situ Culture of Bovine Preantral Follicles are Dose Dependent.

The objective of this study was to evaluate different concentrations of growth hormone (GH) on the development of bovine preantral follicles cultured included in the ovarian tissue (in situ) on the rates of morphologically normal, viable, primordial and developing follicles, as well as the oocyte and follicle diameter and ultrastructural analysis. Ovarian fragments collected from cows with no cross-breeds defined were cultured in situ for 1 and 7 days in minimal essential medium (α-MEM+) supplemented with different concentrations of recombinant human GH (0, 10, 25, 50 ng/ml). The ovarian fragments non-cultured (control) and cultured were processed for classic histology, mechanical isolation and electron transmission microscopy (MET). The parameters underwent anova (Tukey's and Dunnett's tests) and chi-square test (χ(2) ). After 7 days of culture, the treatment with 50 ng/ml GH showed no differences with fresh control (p > 0.05) and had greater effectiveness than in the 0, 10 and 25 ng/ml GH concentrations of the morphologically normal follicles. Regarding the primordial follicles, a reduction was observed in the 50 ng/ml GH concentration concomitant with the significant increase in developing follicles, differing from both the fresh control and the other GH concentrations tested. In addition, 50 ng/ml GH showed a larger follicle and oocyte diameter when compared to the other treatments cultured. Similar structures were ultrastructurally observed in the control group, 50 ng/ml GH. Follicles cultured in 10 ng/ml GH showed nuclear invagination, vacuoles and lesioned basal membrane. Hence, it is concluded that 50 ng/ml GH is the most effective concentration for the development of preantral follicles cultured in situ.

Partial correction of the dwarf phenotype by non-viral transfer of the growth hormone gene in mice: Treatment age is critical.

Non-viral transfer of the growth hormone gene to different muscles of immunodeficient dwarf (lit/scid) mice is under study with the objective of improving phenotypic correction via this particular gene therapy approach. Plasmid DNA was administered into the exposed quadriceps or non-exposed tibialis cranialis muscle of lit/scid mice followed by electroporation, monitoring several growth parameters. In a 6-month bioassay, 50µg DNA were injected three times into the quadriceps muscle of 80-day old mice. A 50% weight increase, with a catch-up growth of 21%, together with a 16% increase for nose-to-tail and tail lengths (catch-up=19-21%) and a 24-28% increase for femur length (catch-up=53-60%), were obtained. mIGF1 serum levels were ~7-fold higher than the basal levels for untreated mice, but still ~2-fold lower than in non-dwarf scid mice. Since treatment age was found to be particularly important in a second bioassay utilizing 40-day old mice, these pubertal mice were compared in a third bioassay with adult (80-day old) mice, all treated twice with 50µg DNA injected into each tibialis cranialis muscle, via a less invasive approach. mIGF1 concentrations at the same level as co-aged scid mice were obtained 15days after administration in pubertal mice. Catch-up growth, based on femur length (77%), nose-to-tail (36%) and tail length (39%) increases was 40 to 95% higher than those obtained upon treating adult mice. These data pave the way for the development of more effective pre-clinical assays in pubertal dwarf mice for the treatment of GH deficiency via plasmid-DNA muscular administration.